EMBO Molecular Medicine is an open access online journal published by Wiley-Blackwell on behalf of EMBO. The quality of the journal is guaranteed by the editorial and advisory boards, consisting of leading researchers in the field of molecular medicine, together with the commitment to scientific excellence and the professionalism of EMBO Editors.
Pulmonary hypertension is a very serious disease that leads to heart failure and death in many patients. Searching for new treatment options, a team headed by Professor Daniela Wenzel and Dr. Alexander Seidinger from the ...
Jul 8, 2024
0
11
Monocytes, a special type of white blood cell, secrete cytokines as inflammatory messengers that are crucial for an appropriate immune response. Researchers at the University Hospital Bonn (UKB) and the University of Bonn ...
Jul 8, 2024
0
31
Fully automated diagnostic techniques, including liquid handling robots, are poised to improve the lives of millions of people living with inflammatory diseases worldwide.
Jun 25, 2024
0
10
Treatment outcomes for breast cancer have become better over the years, but a proportion of breast cancers still recur even after long periods without signs of cancer remaining dormant in the body. Finnish cancer researchers ...
Jun 17, 2024
0
39
Researchers have long known that the body's immune system plays a critical role in fighting off chikungunya virus (CHIKV), but how exactly immune cells coordinate their response has been a mystery—until now.
Apr 29, 2024
0
22
Triple-negative breast cancer (TNBC) is difficult to treat due to its aggressive nature and resistance to chemotherapy. Exciting research published by the University of Southern Denmark sheds light on the mechanisms that ...
Apr 2, 2024
0
49
Chimeric antigen receptor T cells—CAR T cells for short—are immune cells (T cells) that are taken from the body and genetically modified outside the body in the laboratory using transport vehicles for the genes to be ...
Mar 22, 2024
0
0
Researchers at the University of Zurich and the University Hospital Zurich have discovered that a specific mutation in the cancer cells of an aggressive type of blood cancer can prevent novel immunotherapies such as CAR T-cell ...
Mar 21, 2024
0
23
Weizmann Institute scientists have discovered two small molecules that can cross the blood-brain barrier in mice, slowing and even reversing the effects of Huntington's, which is incurable.
Feb 26, 2024
0
40
A Brock-led international research team has discovered an immunotherapy method that could potentially add years to healthy aging. The research, published in the journal EMBO Molecular Medicine, introduces an innovative method ...
Nov 21, 2023
0
164
